Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
No fee travel points cards often provide unique perks. Discover how these benefits can maximize your travel rewards.
19,690 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
The Congressional Budget Office now projects the Old-Age and Survivors Insurance Trust Fund could deplete by 2032, on...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
The administration re-ignites a plan to bar large investors from single-family home purchases. Analysts question whet...
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
A small group of mega-cap stocks can tilt the entire market. This in-depth look explains how the magnificent seven sh...
A major hedge fund recently boosted its Garrett Motion position, highlighting how hybrid powertrain trends are reshap...
VOdds rolls out Odds Scanner, a live odds comparison tool designed for crypto bettors. The platform aggregates prices...
A high-flying AI infrastructure stock surged 176% in a single year. This guide breaks down what powered that move, wh...
A high-profile stance can carry a price in Hollywood. This article explains the financial lessons from Susan Sarandon...
Household bills are climbing again amid a web of factors from aging infrastructure to data-center demand. This report...
Disruption is reshaping markets faster than ever. This article digs into disruption stories: stocks that could be at ...